“USAID, through [PEPFAR], is working closely with the [WHO], the [CDC], and other international partners” to implement “more progressive policies that help ensure that all pregnant mothers get access to lifelong HIV therapy, [and] countries throughout Africa, Asia, and Latin America are increasing mothers’ access to once-daily, lifelong antiretroviral drugs that will protect their babies from infection,” B. Ryan Phelps, a medical officer for prevention of mother-to-child transmission (PMTCT) and pediatric HIV in the USAID’s Office of HIV/AIDS, writes in USAID’s “IMPACTblog” as part of a series on the agency’s activities in global health. “Over a dozen countries are in the process of developing and rolling out universal treatment strategies for pregnant women, and USAID continues to work side-by-side with ministries of health toward the goal of an AIDS-free generation,” he writes, adding, “To further bolster this technical support, USAID recently helped in the creation of an Interagency Task Team implementation toolkit to assist countries as they scale up these strategies” (5/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.